drugset / Trial / NCT00985712

A Study on the Effect of 2 Pen Devices on HbA1c

NCT00985712

Phase 4 Completed 263 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to test the hypothesis that the HumaPen Memoir with memory function, when used over 24 weeks for prandial insulin injections achieves superior glycemic control, when compared to the conventional HumaPen Luxura without memory function.

Timeline

Start
2009-10
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Protein / enzyme biologic Subcutaneous
Background Insulin Lispro Protein / enzyme biologic Subcutaneous